Search research articles
Contact Us
Filters
Showing results (41-50 of 151) with videos related to
Page
of 16
Sort By:
Plos One
|
December 29, 2015
Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
Emily I Chen, Katherine D Crew, Meghna Trivedi, et al.
Journal of Biomedical Optics
|
September 20, 2013
Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography
Molly L Flexman, Hyun K Kim, Jacqueline E Gunther, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 6, 2021
When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management
Samilia Obeng-Gyasi, Charlotte E Coles, Jade Jones, et al.
Breast Cancer Research and Treatment
|
February 13, 2017
Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients
Emerson A Lim, Jacqueline E Gunther, Hyun K Kim, et al.
Breast Cancer Research and Treatment
|
June 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real world
Megan Kruse, Emily Nash Smyth, Lee Bowman, et al.
Breast Cancer Research and Treatment
|
March 26, 2016
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer
Heather Greenlee, Katherine D Crew, Jillian Capodice, et al.
JCO Oncology Practice
|
March 19, 2021
Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care
Tejus Satish, Rohit Raghunathan, Jake G Prigoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
PIK3CA mutation associates with improved outcome in breast cancer
Kevin Kalinsky, Lindsay M Jacks, Adriana Heguy, et al.
Breast Cancer Research and Treatment
|
April 2, 2013
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors
Dawn L Hershman, Heather Greenlee, Danielle Awad, et al.
NPJ Breast Cancer
|
April 25, 2024
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
Sara A Hurvitz, Aditya Bardia, Kevin Punie, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 151) with videos related to
Sort By:
Page
of 16
Plos One
|
December 29, 2015
Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
Emily I Chen, Katherine D Crew, Meghna Trivedi, et al.
Journal of Biomedical Optics
|
September 20, 2013
Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography
Molly L Flexman, Hyun K Kim, Jacqueline E Gunther, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 6, 2021
When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management
Samilia Obeng-Gyasi, Charlotte E Coles, Jade Jones, et al.
Breast Cancer Research and Treatment
|
February 13, 2017
Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients
Emerson A Lim, Jacqueline E Gunther, Hyun K Kim, et al.
Breast Cancer Research and Treatment
|
June 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real world
Megan Kruse, Emily Nash Smyth, Lee Bowman, et al.
Breast Cancer Research and Treatment
|
March 26, 2016
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer
Heather Greenlee, Katherine D Crew, Jillian Capodice, et al.
JCO Oncology Practice
|
March 19, 2021
Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care
Tejus Satish, Rohit Raghunathan, Jake G Prigoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
PIK3CA mutation associates with improved outcome in breast cancer
Kevin Kalinsky, Lindsay M Jacks, Adriana Heguy, et al.
Breast Cancer Research and Treatment
|
April 2, 2013
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors
Dawn L Hershman, Heather Greenlee, Danielle Awad, et al.
NPJ Breast Cancer
|
April 25, 2024
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
Sara A Hurvitz, Aditya Bardia, Kevin Punie, et al.
Page
of 16